• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

FDA counsels on proper insulin injection technique

October 1, 2018 By Sarah Faulkner

FDA insulin pen injectionThe FDA issued a safety communication last week detailing the difference between standard pen needles and safety pen needles, both of which are used to inject medicine via pen injectors.

A standard pen needle usually has an outer cover and a removable inner needle cover – both covers must be removed prior to an injection. A safety pen needle has an outer cover and a fixed inner needle shield. While the outer cover is removed before an injection, the fixed inner needle shield remains in place.

It’s easy to confuse the two types of needles, the FDA noted, and sometimes patients are trained using one type of pen needle rather than the other. Both pen needles can be used with pen injectors.

The U.S. regulatory agency said it has received reports of patients using standard pen needles to inject insulin without removing the inner needle cover, preventing the needle from entering the skin and delivering the insulin. The FDA knows of at least one patient who was hospitalized and later died due to hyperglycemia after incorrectly injecting their insulin.

To ensure the safe use of pen needles, the FDA recommended that patients check each new box of pen needles. The agency also said that patients should consult their healthcare provider if they have any concerns that their pen injector is not working.

The FDA has asked pen needle manufacturers to review their most recent labeling and training materials to evaluate the need for any potential updates. Standard pen needle makers should also consider adding a warning to their products’ labeling, noting that users need to remove both the outer and inner needle cover, according to the FDA.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals, Regulatory/Compliance

IN CASE YOU MISSED IT

  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care
  • Insulet up on Q2 sales beat, raised full-year guidance
  • Aptar acquires Orbital dry powder inhaler license
  • Tandem sinks on Q2 misses, slashed sales guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS